Kazia Therapeutics (KZIA) Amortizatization of Intangibles (2016 - 2018)
Kazia Therapeutics (KZIA) posted Amortizatization of Intangibles of $388953.7 for Q4 2018, down 36.67% on a QoQ basis from $614211.9 in Q4 2017, and down 36.67% year-over-year from $614211.9 in Q4 2017.
Kazia Therapeutics (KZIA) Amortizatization of Intangibles (2016 - 2018) Analysis & Trends
Kazia Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $388953.7 for Q4 2018.
- Quarterly Amortizatization of Intangibles fell 36.67% year-over-year to $388953.7 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $388953.7 (down 36.67% YoY) and the FY2025 annual result came in at $598164.6, down 51.44% from the prior year.
- Amortizatization of Intangibles was $388953.7 for Q4 2018 at Kazia Therapeutics, down from $614211.9 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $614211.9 in Q4 2017 and bottomed at $378292.9 in Q4 2016.
- A 3-year average of $460486.2 and a median of $388953.7 in 2018 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2017 — Amortizatization of Intangibles jumped 62.36% — and 2018, when it tumbled 36.67%.
- Kazia Therapeutics' Amortizatization of Intangibles stood at $378292.9 in 2016, then soared by 62.36% to $614211.9 in 2017, then tumbled by 36.67% to $388953.7 in 2018.
- Business Quant data shows KZIA's Amortizatization of Intangibles at $388953.7 in Q4 2018, $614211.9 in Q4 2017, and $378292.9 in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Kazia Therapeutics | 19.19 Bn | 19.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 388,953.75 |
| Dec 31, 2018 | 388,953.75 |
| Dec 31, 2017 | 614,211.87 |
| Dec 31, 2017 | 614,211.87 |
| Dec 31, 2016 | 378,292.88 |
| Dec 31, 2016 | 378,292.88 |